Genmab Files Annual Report With The U.S. Securities And Exchange Commission
Genmab A/S (Nasdaq: GMAB) announced today that it has filed its Annual Report for the financial year 2024 on Form 20-F with the U.S. Securities and Exchange Commission (SEC), incorporating by ...
Genmab Publishes 2024 Annual Report
Global net sales of EPKINLY/TEPKINLY were USD 281 million in 2024. Net product sales in the U.S. and Japan by Genmab were DKK 1,743 million in 2024 compared to DKK 421 million in 2023. EPKINLY was ...
Brookfield Asset Management Announces Record 2024 Results and 15% Dividend Increase
Over $135 Billion of Capital Inflows; $48Billion of Capital Deployed in 2024Quarterly Fee-Related Earnings up 17% Year-Over-Year to a Record $677 ...
A1 Telekom Austria grows faster in fixed network than with mobile communications
Regional telecommunications group A1 reports slightly higher revenue, more cash flow but lower profits for 2024. Austria's ...